Ken Deal

Ken Deal

Dr. Ken Deal, PhD, MBA, CMRP, Fellow MRIA
Professor
  • Marketing
  • Faculty
  • Tags:
  • mba
  • phd
  • ug

Contact Information

Email: deal@mcmaster.ca
Office: RJC 254
Phone: 905-525-9140 ext. 27430

Professor Deal is an instructor, researcher and consultant, prioritizing marketing analytics, research and modelling to provide significant insights that help organizations build and enhance strategies and guide marketing action. He has extensive experience in the health sector, pharmaceutical research and children’s mental health, many years in the electricity and natural gas sector, and has managed and executed projects across several other industries, including aviation, automotive, tourism, insurance, retail and publishing.

In addition to his academic work, Ken has authored several books on marketing and analytics and is the founder and owner of marketPOWER research inc., and is a recognized and qualified expert in marketing research, often providing expert testimony to the Federal Court of Canada, the Ontario Superior Court of Justice and US courts. He is also a regular instructor at the Institute for Professional Development of the Marketing Research and Intelligence Association and has served on the management board of the Directors College.

Ken’s expertise lies in the area of using sophisticated marketing and marketing research to provide significant insights that help organizations build and enhance marketing strategies. He has developed marketing models to assess the potential of new products, evaluate the effectiveness of advertising and to enhance marketing decisions in a variety of management areas.

Curriculum Vitae

  • Ph.D., Marketing and Management Science, State University of New York at Buffalo
  • M.B.A., State University of New York at Buffalo
  • B.S., State University of New York at Buffalo

Ken’s book, Marketing Research: Methods and Canadian Practice, was published in April 1992. The second edition is now in progress. This book adds to Dr. Deal’s other publications that have appeared in a variety of professional and academic journals. Dr. Deal is Chairman of Marketing at McMaster University (1999-2002), a position he held from 1982 to 1986. He served as President of the Professional Marketing Research Society in 1998/1999, as Vice-President in 1997/1998 and as Past President in 1999/2000. Dr. Deal was elected Lifetime Fellow of the Professional Marketing Research Society in May 2000. He is serving as President of the Canadian Survey Research Society in 2000/2001.

 

Peer Reviewed Research Articles:

Charles E. Cunningham, Heather Rimas, Tracy Vaillancourt, Bailey Stewart, Ken Deal, Lesley Cunningham, Thuva Vanniyasingam, Eric Duku, Don H. Buchanan , Lehana Thabane (2018). “What Anti-bullying Program Designs Motivate Student Intervention in Grades 5 to 8?.” Journal of Clinical Child and Adolescent Psychology, (accepted December 16, 2018) (2017 Impact Factor: 5.014)

Marshall, Deborah, Ken Deal, Barbara Conner-Spady, Eric Bohm, Gillian Hawker, Lynda Loucks, Karen MacDonald, Tom Noseworthy (2018). “How do Patients Trade-Off Surgeon Choice and Waiting Times for Total Joint Replacement: A Discrete Choice Experiment.” Osteoarthritis and Cartilage, 26 (2018) 522-530. https://doi.org/10.1016/j.joca.2018.01.008  (accepted January 11, 2018.) (2016 Impact Factor: 4.742; 5-Year Impact Factor: 5.070)

Ghasemaghaei, Maryam, Seyed Pouyan, Ken Deal, Khaled Hassanein (2017). “Reviews’ Length and Sentiment as Correlates of Online Reviews’ Ratings”, Internet Research, accepted December 28, 2017.  (2016 Impact Factor: 2.931; 5-year Impact Factor (2016): 4.580)

Wymbs, FA, Yvonne  Chen, Heather Rimas, Ken Deal, Daniel A Waschbusch, William  E Pelham (2017). “Examining Parents’ Preferences for Group Parent Training for ADHD When Individual Parent Training is Unavailable.” Journal of Child and Family Studies, accepted Sept 30, 2016, printed 26:888-904. (Impact factor 1.386). Published online 02nov16, DOI 10.1007/s10826-016-0588-1, http://rdcu.be/mir8

Marshall, Deborah A, Ken Deal, Yvonne Bombard, Natasha Leighl, Karen V MacDonald, Maureen Trudeau, (2016). “How do Women Trade-Off Benefits and Risks in Chemotherapy Treatment Decisions Based on Gene Expression Profiling for Early-Stage Breast Cancer? A Discrete Choice Experiment.” BMJ Open, 2016;6:e010981. Doi:10.1136/bmjopen-2015-010981. (2014 impact factor 2.271)

Karen V MacDonald, Yvonne Bombard, Ken Deal, Maureen Trudeau, Natasha Leighl, Deborah A Marshall (2016). “The Influence of Gene Expression Profiling on Decisional Conflict in Decision-Making for Early-Stage Breast Cancer Chemotherapy”, European Journal of Cancer. 2016;61:85-93. (Accepted March 3, 2016, printed July2016. 2014 impact factor 5.417)

Charles E. Cunningham, Heather Rimas, Stephanie Mielko, Cailin Mapp, Lesley Cunningham, Don Buchanan, Tracy Vaillancourt, Yvonne Chen, Ken Deal & Madalyn Marcus (2016) What Limits the Effectiveness of Antibullying Programs? A Thematic Analysis of the Perspective of Teachers, Journal of School Violence, 15:4, 460-482, DOI: 10.1080/15388220.2015.1095100

Cunningham, Charles E., Heather Rimas ,Yvonne Chen, Ken Deal, Patrick McGrath, Patricia Lingley-Pottie, Graham J. Reid, Ellen Lipman, and Penny Corkum (2015). “Modeling Parenting Programs as an Interim Service for Families Waiting for Children’s Mental Health Treatment,” Journal of Clinical Child and Adolescent Psychology, June, Vol. 44(4), pp. 616-629. Accepted on 10dec13, published online on 04apr2014 DOI: 10.1080/15374416.2014.888666. (2012 Impact Factor: 2.665)

Wymbs, FA, CE Cunningham, Y Chen, H Rimas, K Deal, WE Pelham, DA Waschbusch (2015). “Examining Parents’ Preferences for Group and Individual Parent Training For Children with ADHD Symptoms,” Journal of Clinical Child and Adolescent Psychology, April, 2015, 45(5), 614–631, ISSN: 1537-4416 print/1537-4424 online, DOI: 10.1080/15374416.2015.1004678, accepted on 02nov14. (2012 Impact Factor: 2.665)

Bombard Y, Rozmovits L, Trudeau M, Leighl NB, Deal K, Marshall DA (2015). “The value of personalizing medicine: Medical oncologists’ views on gene expression profiling in breast cancer treatment,” The Oncologist, Vol 20, pp. 351-356; first published on March 6, 2015;doi:10.1634/theoncologist. Accepted Nov 2014, 2015. (2013/2014 Impact Factor: 4.54)

Cunningham, CE, Y Chen, T Vaillancourt, H Rimas, K Deal, Lesley J Cunningham, Jenna Ratcliffe (2015). “Modeling the Anti–Cyberbullying Preferences of University Students: Adaptive Choice–based Conjoint Analysis,” Aggressive Behavior, Vol. 41, pp. 369-385. Accepted for publication in final form on 31jul14, published online 17sep14, DOI: 10.1002/ab.21560. (2011 Impact Factor: 2.63)

Bombard Y, Rozmovits L, Trudeau M, Leighl NB, Deal K, Marshall DA. “Patients’ perceptions of gene expression profiling in breast cancer treatment decisions.” Current Oncology. 2014; 21(2): e203-11. doi: 10.3747/co.21.1524. (2011 Impact Factor: 2.473)

Bombard, Y, L Rozmovits, M Trudeau, N Leighl, K Deal, D Marshall (2014). “Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment,” Current Oncology, Vol 21, 3, 426-433. (2011 Impact Factor: 2.473)

Deal, Ken, Karim Keshavjee, Sue Troyan, Robert Kyba, Anne Marie Holbrook (2014). “Physician and Patient Willingness to Pay for Electronic Cardiovascular Disease Management,” International Journal of Medical Informatics, Vol 83 (2014), 517-528. (2014 Impact Factor: 2.716; 5-Year Impact Factor: 3.214)

Deal, Ken (2014), “Segmenting Patients and Physicians using Preferences from Discrete Choice Experiments,” The Patient: Patient-Centred Outcomes Research, Vol 7 (2014), 5-21. Published online: 11dec13. (DOI: 10.1007/s40271-013-0037-9) (2014 Impact Factor: 1.96) Invited article.

Deal, Ken, Deborah Marshall, Dominika Dabrowski, Alina Charter, Margaret Bukoski, Paul Moayyedi (2013), “Assessing the Value of Symptom Relief with Gastroesophageal Reflux Disease (GERD) Treatment: Willingness-to-Pay Using a Discrete Choice Experiment,” Value in Health, June, Vol. 16 (4), pp. 588-598. (2012 Impact Factor: 2.191; 5 Year Impact Factor: 2.903)

Cunningham, Charles E., Yvonne Chen, Ken Deal, Heather Rimas, Patrick McGrath, Graham Reid, Ellen Lipman, Penny Corkum (2013), The Interim Service Preferences of Parents Waiting for Children’s Mental Health Treatment: A Discrete Choice Conjoint Experiment, Journal of Abnormal Child Psychology, (August, 2013), 41, pp 865-877, published online 24 February 2013, DOI 10.1007/s10802-013-9718-s. (2012 Impact Factor: 3.005)

Cunningham, Charles E., Linda Kostrzewa, Heather Rimas, Yvonne Chen, Ken Deal, Susan Blatz, Alida Bowman, Don H. Buchanan, Randy Calvert, Barbara Jennings (2013), Modeling Organizational Justice Improvements in a Pediatric Health Service, The Patient: Patient-Centred Outcomes Research, Vol. 6, pp. 45-59. DOI 10.1007/s40271-013-0002-7 (Published online 01February2013). (2014 Impact Factor: 1.96)

Conference Presentations

Marshall DA, Deal K, Conner-Spady B, Bohm E, Hawker G, Loucks L, Regier DA, Sanmartin C, MacDonald KV, Noseworthy T. Comparing Alternative Opt-Out Formats on Patient Preferences for Surgeon Selection and Waiting Times (2017). 6th Meeting of the International Academy of Health Preference Research; Boston, MA, USA: July 6-7.

Charles Cunningham, Heather Rimas, Bailey Stewart, Tracy Vaillancourt, Eric Duku, Lehana Thabane, Lesley Cunningham, Donald Buchanan, Ken Deal, Stephanie Mielko (2017). Does dispositional reactance moderate the influence of barriers to the implementation of anti-bullying programs on psychological reactance by teachers? Canadian Psychological Association 77th Annual Convention, June, 2017.

Ghasemaghaei, Maryam, Seyed Pouyan Eslami, Ken Deal, Khaled Hassanein (2016). Consumers’ Attitude toward Insurance Companies: A Sentiment Analysis of Online Consumer Reviews, 22nd Americas Conference on Information Systems, San Diego, August 11-14 2016.

Charles Cunningham, Thabane L., Eric Duku, Michael Boyle, Ken Deal, Donald Buchanan, Lesley Cunningham, Cailin Mapp, Stephanie Mielko, Tracy Vaillancourt, Heather, Raiyan Chowdhury (2016). Does Psychological Reactance Limit the Effectiveness of Anti-bullying Programs? Canadian Psychological Association 77th Annual Convention, June 10, 2016.

Deal, K, Marshall, D, Bombard, Y, MacDonald, K, Trudeau, M, Leighl, N (2015). Understanding risk-benefit trade-offs of genomic testing in chemotherapy treatment decisions for breast cancer. International Health Economics Association (IHEA) Conference 2015; Milan, Italy: July 14, 2015.

Bombard Y, Rozmovits L, Trudeau M, Leighl N, Deal K, Marshall DA (2014). Medical oncologists’ views on gene expression profiling in breast cancer treatment. Ontario Institute for Cancer Research (OICR) Annual Health Services Research Meeting; Toronto, Ontario: June 19.

Marshall DA, Bombard Y, Trudeau M, Leighl N, MacDonald K, Deal K (2014). Patient preferences: understanding risk-benefit trade-offs of genomic testing in chemotherapy decisions for breast cancer patients. Health Technology Assessment International (HTAi) Annual Scientific Conference; Washington DC, USA: June 14-18.

Bombard Y, Rozmovits L, Trudeau M, Leighl N, Deal K, Marshall DA (2014). The value of personalizing medicine: Medical oncologists’ views on gene expression profiling in breast cancer treatment. Health Technology Assessment International (HTAi) Annual Scientific Conference; Washington DC, USA: June 14-18.

Bombard Y, Rozmovits L, Trudeau M, Leighl N, Deal K, Marshall DA (2014). The value of personalizing medicine: Medical oncologists’ views on gene expression profiling in breast cancer treatment. Canadian Association for Health Services and Policy Research (CAHSPR) conference; Toronto, Ontario: May 13-15.

Bombard Y, Rozmovits L, Trudeau M, Leighl N, Deal K, Marshall DA (2014). The value of personalizing medicine: Medical oncologists’ views on gene expression profiling in breast cancer treatment. Canadian Centre for Applied Research in Cancer Control (ARCC); Toronto, Ontario: May 12.

MacDonald K, Marshall DA, Bombard Y, Trudeau M, Leighl N, Deal K (2014). The influence of gene expression profiling on decisional conflict in chemotherapy treatment decisions-making for early-stage breast cancer. Canadian Centre for Applied Research in Cancer Control (ARCC); Toronto, Ontario: May 12.

Deal K, Bombard Y, Trudeau M, Leighl N, Pykerman K, Marshall DA (2013). Understanding Risk-Benefit Trade-offs of Genomic Testing in Chemotherapy Treatment Decisions for Breast Cancer. Conjoint Analysis in Healthcare, Sawtooth Software Conference; Dana Point, California, USA: October 16.

Bombard Y, Rozmovits L, Trudeau M, Leighl N, Deal K, Marshall DA (2013). Access to personalized medicine: the case of gene expression profiling in breast cancer. Canadian Association for Health Services and Policy Research (CAHSPR) conference; Vancouver, British Columbia: May 28-30.

Bombard Y, Rozmovits L, Trudeau M, Leighl N, Deal K, Marshall DA (2013). Access to personalized medicine: the case of gene expression profiling in breast cancer. Canadian Centre for Applied Research in Cancer Control (ARCC) conference; Vancouver, British Columbia: May 27.

Marshall D, Bombard Y, Trudeau M, Leighl N, Pykerman K, Deal K (2013). Patient preferences: Understanding Risk-Benefit Trade-offs of Genomic Testing in Chemotherapy Treatment Decisions for Breast Cancer Patients. Canadian Centre for Applied Research in Cancer Control (ARCC) conference; Vancouver, British Columbia: May 27.